Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Operating Margin: 2021-2024

Historic Operating Margin for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -46.11%.

  • Biofrontera's Operating Margin fell 3480.00% to -89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.40%, marking a year-over-year increase of 736.00%. This contributed to the annual value of -46.11% for FY2024, which is 2044.00% up from last year.
  • Per Biofrontera's latest filing, its Operating Margin stood at -46.11% for FY2024, which was up 30.72% from -66.56% recorded in FY2023.
  • Over the past 5 years, Biofrontera's Operating Margin peaked at -46.11% during FY2024, and registered a low of -104.57% during FY2021.
  • Moreover, its 3-year median value for Operating Margin was -64.80% (2022), whereas its average is -59.16%.
  • In the last 5 years, Biofrontera's Operating Margin skyrocketed by 3,977bps in 2022 and then tumbled by 176bps in 2023.
  • Over the past 4 years, Biofrontera's Operating Margin (Yearly) stood at -104.57% in 2021, then skyrocketed by 3,977bps to -64.80% in 2022, then plummeted by 176bps to -66.56% in 2023, then skyrocketed by 2,044bps to -46.11% in 2024.